STAAR Surgical Company Forecast, price target & analysts
STAAR Surgical Company Target price 2025 - Analyst rating & recommendation
STAAR Surgical Company Classifications & Recommendation:
STAAR Surgical Company Price Target
| Target Price | $20.40 |
| Price | $16.92 |
| Potential |
20.57%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target STAAR Surgical Company 2026 .
The average STAAR Surgical Company target price is $20.40.
This is
20.57%
register free of charge
$55.27
226.67%
register free of charge
$13.13
22.40%
register free of charge
|
|
| A rating was issued by 20 analysts: 8 Analysts recommend STAAR Surgical Company to buy, 11 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the STAAR Surgical Company stock has an average upside potential 2026 of
20.57%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 313.90 | 260.97 |
| 2.64% | 16.86% | |
| EBITDA Margin | -2.13% | -11.84% |
| 120.69% | 455.54% | |
| Net Margin | -6.44% | -30.36% |
| 197.23% | 371.55% |
16 Analysts have issued a sales forecast STAAR Surgical Company 2025 . The average STAAR Surgical Company sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an STAAR Surgical Company EBITDA forecast 2025. The average STAAR Surgical Company EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 STAAR Surgical Company Analysts have issued a net profit forecast 2025. The average STAAR Surgical Company net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.41 | -1.60 |
| 195.35% | 290.24% | |
| P/E | negative | |
| EV/Sales | 2.36 |
16 Analysts have issued a STAAR Surgical Company forecast for earnings per share. The average STAAR Surgical Company EPS is
This results in the following potential growth metrics and future valuations:
STAAR Surgical Company...
Current STAAR Surgical Company Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 27 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 21 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 27 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 27 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
